The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials

A clear evidence on the benefits of somatostatin analogues (SA) on liver outcome in patients affected by polycystic liver disease is still lacking. We performed a meta-analysis of RCTs and a trial sequential analysis (TSA) evaluating the effects of SA in adult patients with polycystic liver disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Garofalo, Carlo, Capuano, Ivana, Pennino, Luigi, De Gregorio, Ilaria, Riccio, Eleonora, Provenzano, Michele, Crocetto, Felice, Buonanno, Pasquale, Pandolfo, Savio Domenico, Andreucci, Michele, Pisani, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648823/
https://www.ncbi.nlm.nih.gov/pubmed/34873228
http://dx.doi.org/10.1038/s41598-021-02812-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648823/
https://www.ncbi.nlm.nih.gov/pubmed/34873228
http://dx.doi.org/10.1038/s41598-021-02812-z

Ejemplares similares